Skip to main content

Retail Clinics

  • FDA recommends limiting use of simvastatin in 80-mg strength

    SILVER SPRING, Md. — The Food and Drug Administration is seeking to limit the use of high doses of a drug for high cholesterol due to the risk of a muscle injury known as myopathy.

  • FDA approves labeling change for Eli Lilly insulin product

    INDIANAPOLIS — Patients with Type 1 diabetes using an insulin product made by Eli Lilly can store it in their pumps for longer periods of time, while children using it have additional options, thanks to a labeling change approved Wednesday by the Food and Drug Administration.

  • Walgreens, NMPG develop coordinated healthcare program

    DEERFIELD, Ill. — Walgreens and Northwestern Memorial Physicians Group of Chicago on Wednesday announced a new coordinated healthcare program in which Walgreens will share the results of appropriately timed pharmacist clinical interventions with primary care physicians of selected patients.

  • Statin users can save money if they adhere to therapies, Medco finds

    FRANKLIN LAKES, N.J. — In a year and a half, patients taking statins to lower their cholesterol can save more than $900 when they take their medications as prescribed, according to a new study in the June 1 issue of the American Journal of Cardiology.

    The study, conducted by pharmacy benefit manager Medco Health Solutions’ research subsidiary, the Medco Research Institute, found that patients who adhered to their therapies saved as much as $944 over 18 months because they experienced fewer cardiovascular problems leading to hospitalization.

  • U.S. News ranks best dieting plans

    WASHINGTON — U.S. News Media Group on Tuesday ranked the best dieting plans by health goal — identifying the best plans for weight loss, heart health and diabetes.

    Building on the company’s experience evaluating hospitals, U.S. News developed five diet rankings to address a broad range of consumers' dieting goals and needs. Diets were ranked based on ratings from an independent panel of 22 experts.

  • Mintel: Many African-Americans diet to maintain general wellness, not weight

    CHICAGO — A new report by Mintel may shed new light on the reasons why African-Americans diet.

    According to the research, while 70% of African-American adults surveyed said they limit the amount and/or kind of food they eat to boost their general wellness, 52% are eating healthier to prevent or control high blood pressure and 46% said they follow a diet to maintain their current weight.

  • Actavis granted final approval for generic Ambien CR

    MORRISTOWN, N.J. — The Food and Drug Administration has given final approval to a generic drug for insomnia made by Actavis, the drug maker said Monday.

    The FDA approved the company’s zolpidem tartrate extended-release tablets in the 12.5-mg strength. The drug, which is a Schedule IV controlled substance, is a generic version of Sanofi’s Ambien CR. Actavis was the first company to launch a generic version of the drug in the 6.25-mg strength in October 2010.

  • Topaz seeks FDA approval for head lice treatment

    HORSHAM, Pa. — The Food and Drug Administration has accepted a regulatory approval application for a head lice treatment made by Topaz Pharmaceuticals, Topaz said Tuesday.

    Topaz is seeking approval for ivermectin topical cream, for treating head lice in children and adults.

X
This ad will auto-close in 10 seconds